Vargas-Montes M, Fasquelle F, Cardona N, Gomez-Marin J, Betbeder D
BMC Infect Dis. 2025; 25(1):279.
PMID: 40011842
PMC: 11866635.
DOI: 10.1186/s12879-025-10656-5.
Geng X, Li R, Du J, Zhang M, Jiang W, Sun Q
Pathogens. 2025; 14(2).
PMID: 40005546
PMC: 11858468.
DOI: 10.3390/pathogens14020171.
Hosseini S, Hashemi S, Siamian D, Asghari A, Fathollahzadeh M, Majidiani H
Clin Exp Vaccine Res. 2025; 14(1):86-100.
PMID: 39927227
PMC: 11799584.
DOI: 10.7774/cevr.2025.14.e4.
Chyb M, Ferra B, Kawka M, Skwarecka M, Dziadek B, Gatkowska J
Front Immunol. 2024; 15:1480349.
PMID: 39726608
PMC: 11670819.
DOI: 10.3389/fimmu.2024.1480349.
Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M
Int J Nanomedicine. 2024; 19:12421-12438.
PMID: 39600411
PMC: 11590659.
DOI: 10.2147/IJN.S483626.
Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis.
Reis T, Siqueira V, Ferreira S, Domann N, Rodrigues Junior B, Fleury A
Rev Inst Med Trop Sao Paulo. 2024; 66:e61.
PMID: 39417497
PMC: 11469426.
DOI: 10.1590/S1678-9946202466061.
Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?.
Prandovszky E, Severance E, Splan V, Liu H, Xiao J, Yolken R
Front Cell Infect Microbiol. 2024; 14:1415079.
PMID: 39403206
PMC: 11471644.
DOI: 10.3389/fcimb.2024.1415079.
α2,6 sialylation distinguishes a novel active state in CD4 and CD8 cells during acute infection.
Sierra-Ulloa D, Fernandez J, Cacelin M, Gonzalez-Aguilar G, Saavedra R, Tenorio E
Front Immunol. 2024; 15:1429302.
PMID: 39253089
PMC: 11381403.
DOI: 10.3389/fimmu.2024.1429302.
TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches.
Majidiani H, Pourseif M, Kordi B, Sadeghi M, Najafi A
BMC Infect Dis. 2024; 24(1):886.
PMID: 39210269
PMC: 11361240.
DOI: 10.1186/s12879-024-09807-x.
The effect of infection with in inducing interferon-gamma in breast cancer patients.
Azab Hameed F, Khalaf A
Arch Razi Inst. 2024; 79(1):138-143.
PMID: 39192947
PMC: 11345480.
DOI: 10.32592/ARI.2024.79.1.138.
Interleukins IL33/ST2 and IL1-β in Intrauterine Growth Restriction and Seropositivity of Anti- Antibodies.
Franco-De Leon K, Camarena E, Pereira-Suarez A, Barrios-Prieto E, Soto-Venegas A, Hernandez-Nazara Z
Microorganisms. 2024; 12(7).
PMID: 39065188
PMC: 11278629.
DOI: 10.3390/microorganisms12071420.
Contrasting Disease Progression, Microglia Reactivity, Tolerance, and Resistance to Infection in Two Mouse Strains.
Diniz D, de Oliveira J, Guerreiro L, de Menezes G, de Assis A, Duarte T
Biomedicines. 2024; 12(7).
PMID: 39061995
PMC: 11274029.
DOI: 10.3390/biomedicines12071420.
Transcriptomic analysis of reproductive organs of pregnant mice post infection reveals the potential factors that contribute to poor prognosis.
Deng M, Chen J, Yang J, Ma J, Shu F, Zou F
Front Microbiol. 2024; 15:1431183.
PMID: 39006750
PMC: 11239361.
DOI: 10.3389/fmicb.2024.1431183.
Exploring the potential of Toxoplasma gondii in drug development and as a delivery system.
Yoon C, Ham Y, Gil W, Yang C
Exp Mol Med. 2024; 56(2):289-300.
PMID: 38297164
PMC: 10907749.
DOI: 10.1038/s12276-024-01165-7.
Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Ameliorate Murine Chronic Toxoplasmosis.
Sarhan M, Felemban S, Alelwani W, Sharaf H, Abd El-Latif Y, Elgazzar E
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256946
PMC: 10819917.
DOI: 10.3390/ph17010113.
Positive Toxoplasma IgG Serology Is Associated with Increased Overall Mortality - A Propensity Score-Matched Analysis.
Montalbano G, Kung V, Franco-Paredes C, Vargas Barahona L, Chastain D, Tuells J
Am J Trop Med Hyg. 2023; 110(2):238-245.
PMID: 38109768
PMC: 10859811.
DOI: 10.4269/ajtmh.23-0537.
A novel mRNA vaccine, TGGT1_278620 mRNA-LNP, prolongs the survival time in BALB/c mice with acute toxoplasmosis.
Zhang Y, Li S, Chu H, Li J, Lu S, Zheng B
Microbiol Spectr. 2023; 12(1):e0286623.
PMID: 38038457
PMC: 10783036.
DOI: 10.1128/spectrum.02866-23.
Structural basis of Irgb6 inactivation by Toxoplasma gondii through the phosphorylation of switch I.
Okuma H, Saijo-Hamano Y, Yamada H, Sherif A, Hashizaki E, Sakai N
Genes Cells. 2023; 29(1):17-38.
PMID: 37984375
PMC: 11448365.
DOI: 10.1111/gtc.13080.
Newly fabricated zinc oxide nanoparticles loaded materials for therapeutic nano delivery in experimental cryptosporidiosis.
Hamdy D, Ismail M, El-Askary H, Abdel-Tawab H, Ahmed M, Fouad F
Sci Rep. 2023; 13(1):19650.
PMID: 37949873
PMC: 10638360.
DOI: 10.1038/s41598-023-46260-3.
P21 recombinant protein modulates infection in different experimental models of the human maternal-fetal interface.
de Souza G, Teixeira S, Fajardo Martinez A, Silva R, Luz L, de Lima Junior J
Front Immunol. 2023; 14:1243480.
PMID: 37915581
PMC: 10617204.
DOI: 10.3389/fimmu.2023.1243480.